Marianne Coste‐Burel

1.8k citations

41 papers · 879 indexed · h-index 17

Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 9
- Viral gastroenteritis research and epidemiology 4
- COVID-19 Clinical Research Studies 4
Transplantation top 10%
Oncology top 10%
- Viral-associated cancers and disorders 10
- Polyomavirus and related diseases 6
Hematology top 10%
- Hematopoietic Stem Cell Transplantation 6
Hepatology top 10%
Epidemiology
- Cytomegalovirus and herpesvirus research 11
Cardiology and Cardiovascular Medicine
- Viral Infections and Immunology Research 5

Co-authors: Berthe‐Marie Imbert‐Marcille Céline Bressollette‐Bodin Maryvonne Hourmant Véronique Sebille Sylviane Billaudel Patrice Chevallier Thierry Guillaume Bernard Besse
Cited by: Infectious Diseases Transplantation Oncology
Partner nations: France Canada United States

In The Last Decade

Marianne Coste‐Burel

40 papers receiving 867 citations

Peers

Countries citing papers authored by Marianne Coste‐Burel

Since Specialization

Citations

This map shows the geographic impact of Marianne Coste‐Burel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marianne Coste‐Burel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marianne Coste‐Burel more than expected).

Fields of papers citing papers by Marianne Coste‐Burel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marianne Coste‐Burel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marianne Coste‐Burel. The network helps show where Marianne Coste‐Burel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marianne Coste‐Burel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marianne Coste‐Burel Line = papers co-authored together Marianne Coste‐Burel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Measles in vulnerable populations: An outbreak in Roma settlements of Loire‐Atlantique, France, 2019 M. Lefèbvre,Louis J. Gross,R. Ollivier,Sébastien Bailly,Marianne Coste‐Burel,J. Coutherut,Julia Dina	2023	1
2	B Cell Aplasia Is the Most Powerful Predictive Marker for Poor Humoral Response after BNT162b2 mRNA SARS-CoV-2 Vaccination in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Maxime Jullien,Amandine Le Bourgeois,Marianne Coste‐Burel,Pierre Péterlin,Alice Garnier,Marie Rimbert,Berthe‐Marie Imbert,Steven Le Gouill,Philippe Moreau,Beatrice Mahé,Viviane Dubruille,Nicolas Blin,Anne Lok,Cyrille Touzeau,Thomas Gastinne,Benoît Tessoulin,Sophie Vantyghem,Marie C. Béné,Thierry Guillaume,Patrice Chevallier	2022	9
3	Severity of parechovirus infections in infants under 3 months of age and comparison with enterovirus infections: A French retrospective study S. Marchand,É. Launay,Isabelle Schuffenecker,Christèle Gras‐Le Guen,Berthe‐Marie Imbert‐Marcille,Marianne Coste‐Burel	2021	4
4	An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains Elisabeth André‐Garnier,Bernard Besse,Audrey Rodallec,Olivier Ribeyrol,Virginie Ferré,C. Luco,L Le Guen,Nathalie Bourgeois,Jérôme Gournay,Eric Billaud,F. Raffi,Marianne Coste‐Burel,Berthe‐Marie Imbert‐Marcille	2017	12
5	Variability in the diagnostic performance of a bedside rapid diagnostic influenza test over four epidemic seasons in a pediatric emergency department Estelle Avril,Sylvie Lacroix,Bénédicte Vrignaud,A. Moreau-Klein,Marianne Coste‐Burel,É. Launay,Christèle Gras‐Le Guen	2016	9
6	New Introductions of Enterovirus 71 Subgenogroup C4 Strains, France, 2012 Isabelle Schuffenecker,Cécile Henquell,Audrey Mirand,Marianne Coste‐Burel,Stéphanie Marque‐Juillet,Delphine Desbois,Gisèle Lagathu,Laure Bornebusch,Jean‐Luc Bailly,Bruno Lina	2014	12
7	Multiplexed infectious protein microarray immunoassay suitable for the study of the specificity of monoclonal immunoglobulins Delphine Féron,Cathy Charlier,Victor Gourain,Laurent Garderet,Marianne Coste‐Burel,Patrice Le Pape,Pierre Weigel,Yannick Jacques,Sylvie Hermouet,Edith Bigot‐Corbel	2012	16
8	Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation Zinaida Perić,Xavier Cahu,Patrice Chevallier,Éolia Brissot,Florent Malard,Thierry Guillaume,J. Delaunay,Sameh Ayari,Viviane Dubruille,Steven Le Gouill,Beatrice Mahé,Thomas Gastinne,Nicolas Blin,Beatrice Saulquin,J-L Harousseau,Philippe Moreau,Nöel Milpied,Marianne Coste‐Burel,B-M Imbert-Marcille,Mohamad Mohty	2011	57
9	Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation Zinaida Perić,Xavier Cahu,Patrice Chevallier,Éolia Brissot,Florent Malard,Thierry Guillaume,J. Delaunay,Sameh Ayari,Viviane Dubruille,Steven Le Gouill,Beatrice Mahé,Thomas Gastinne,Nicolas Blin,Beatrice Saulquin,Harousseau Jl,Philippe Moreau,Marianne Coste‐Burel,B-M Imbert-Marcille,Mohamad Mohty	2011	13
10	Viral DNA contamination is responsible for Epstein–Barr virus detection in cytotoxic T lymphocytes stimulated in vitro with Epstein–Barr virus B-lymphoblastoid cell line Mathilde Berthomé,Géraldine Gallot,Régine Vivien,Béatrice Clemenceau,Jean‐Michel Nguyen,Marianne Coste‐Burel,Henri Vié	2010	2
11	Human papillomavirus genotype distribution in cervical samples collected in routine clinical practice at the Nantes University Hospital, France E. Vaucel,Marianne Coste‐Burel,Christian Laboisse,André Dahlab,Patrice Lopès	2010	6
12	Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source Patrice Chevallier,Imen Hebia-Fellah,Lucie Planche,Thierry Guillaume,Céline Bressollette‐Bodin,Marianne Coste‐Burel,Fanny Rialland,Mohamad Mohty,B-M Imbert-Marcille	2009	63
13	Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre‐emptive therapy Céline Bressollette‐Bodin,Marianne Coste‐Burel,Bernard Besse,Elisabeth André‐Garnier,Virginie Ferré,Berthe‐Marie Imbert‐Marcille	2008	25
14	T cell repertoire and Epstein–Barr virus-specific T cell response in chronic active Epstein–Barr virus infection: A case study Géraldine Gallot,M. Hamidou,Béatrice Clemenceau,Joëlle Gaschet,Pierre Tiberghien,Christophe Ferrand,Régine Vivien,S. Barbarot,Marianne Coste‐Burel,Anne Moreau,Henri Vié	2006	2
15	Evidence of recombination in natural populations of hepatitis A virus Mauro Costa‐Mattioli,Virginie Ferré,Didier Casañe,Raoul Perez-Bercoff,Marianne Coste‐Burel,Berthe-Marie Imbert-Marcille,Élisabeth André,Céline Bressollette‐Bodin,Sylviane Billaudel,Juan Cristina	2003	40
16	Le virus BK : état des connaissances en 2003 et particularités de l‘infection en transplantation rénale Céline Bressollette‐Bodin,Marianne Coste‐Burel,M. Hourmant,Karine Renaudin,Berthe‐Marie Imbert‐Marcille	2003	1
17	Application of a Real-Time Polymerase Chain Reaction with Internal Positive Control for Detection and Quantification of Enterovirus in Cerebrospinal Fluid Serge Monpoeho,Marianne Coste‐Burel,Mauro Costa‐Mattioli,Bernard Besse,J. J. Chomel,Sylviane Billaudel,V. Ferr x E	2002	58
18	Epstein–Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation Nöel Milpied,Marianne Coste‐Burel,Françoise Accard,Anne Moreau,Philippe Moreau,Richard Garand,JL Harousseau	1999	54
19	Clinical and practical value of human cytomegalovirus DNAemia detection by semi-nested PCR for follow-up of BMT recipients. B-M Imbert-Marcille,Nöel Milpied,Marianne Coste‐Burel,Béatrice Richet,Philippe Moreau,Harousseau Jl,Sylviane Billaudel	1995	9
20	Detection of human papillomavirus in squamous intraepithelial lesions by consensus and type-specific polymerase chain reaction Marianne Coste‐Burel,Bernard Besse,Aurélie Moreau,Berthe‐Marie Imbert,A. Mensier,P. Sagot,Patrice Lopès,Sylviane Billaudel	1993	7

About Marianne Coste‐Burel

Marianne Coste‐Burel is a scholar working on Infectious Diseases, Hematology and Epidemiology, having authored 41 papers that have together received 879 indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (11 papers), Viral-associated cancers and disorders (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Polyomavirus and related diseases (6 papers), Hematopoietic Stem Cell Transplantation (6 papers), Viral Infections and Immunology Research (5 papers), Viral gastroenteritis research and epidemiology (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Infectious Diseases (347 citations), Transplantation (36 citations) and Oncology (350 citations). Marianne Coste‐Burel has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Berthe‐Marie Imbert‐Marcille, Céline Bressollette‐Bodin, Maryvonne Hourmant, Véronique Sebille, Sylviane Billaudel, Patrice Chevallier, Thierry Guillaume, Bernard Besse, Nöel Milpied and Philippe Moreau.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact